Previous 10 |
home / stock / ablyf / ablyf news
Analysis of top Seeking Alpha coverage: Ablynx Today we will discuss the hostile takeover bid from Novo Nordisk ( NVO ) for clinical-stage Belgian biotech company Ablynx ( OTCPK:ABLYF ). On Monday , Novo made a euro 2.6 billion ($3.1 billion) offer to acquire Ablynx. Novo has offered ...
"There is no more disastrous mania, no more dangerous whim, than the speculation over roads not taken." - Juan Gabriel Vásquez, The Sound of Things Falling It was a good start for the markets in the first holiday shortened week of 2018. The Dow hit 25,000 for the first time ever and p...
Novo Nordisk (NYSE: NVO ) has made a €2.6B ($3.1B) offer to acquire Ablynx ( OTCPK:ABLYF )(NASDAQ: ABLX ). Novo announced its €28 per share bid after the Belgian biotech rejected earlier approaches. Analysts believe Novo will have to sweeten its offer to close the deal. Jeffe...